R L MARESCA

Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore - Centre for Endoscopic Research Therapeutics and Training (CERTT), Rome, Italy (Luis Marín Calderón, Rossella Maresca, Frederico Barbaro, Cristiano Spada).

36 publications 1956 – 2026 ORCID

What does R L MARESCA research?

R L Maresca studies innovative endoscopic techniques for removing lesions and managing complications in the gastrointestinal tract, especially those related to conditions like inflammatory bowel disease and cancers. He investigates methods such as endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR), which are less invasive than traditional surgery and can lead to better patient outcomes. Additionally, his research looks into the effects of external factors like air pollution on liver health and how infections can influence treatment responses in patients with IBD.

Key findings

  • Endoscopic submucosal dissection (ESD) effectively removed gastric subepithelial lesions in 96.3% of cases with a complication rate of only 7%.
  • In a study on colon lesions, cancer was found in 12% of patients, and while 59.1% had non-curative resections, only 7.6% required additional surgery.
  • Patients treated with multistrain probiotics and vitamin D for irritable bowel syndrome showed a significant reduction in gut permeability markers by 19.5 ng/mL after 12 weeks.
  • Among 560 patients who had ESD wound closure, delayed bleeding occurred in 1.7% compared to 5.6% in those without closure, showing a clear benefit of this technique.
  • Twenty percentage of patients with large nonampullary duodenal tumors experienced recurrence within an average follow-up of 20.5 months, emphasizing the need for regular monitoring.

Frequently asked questions

Does Dr. Maresca study gastrointestinal bleeding?
Yes, Dr. Maresca has researched ways to manage gastrointestinal bleeding in cancer patients, focusing on new imaging techniques and advanced treatment options.
What treatments has Dr. Maresca researched?
He has studied endoscopic procedures like ESD and EMR, which are advanced methods for removing lesions in the gastrointestinal tract, as well as the effectiveness of probiotics for gut health.
Is Dr. Maresca's work relevant to patients with inflammatory bowel disease?
Absolutely, his research directly addresses treatment options and outcomes for patients with inflammatory bowel disease, including complications and the impact of air pollution on liver health.
What are the outcomes of treatments for colorectal lesions that Dr. Maresca researched?
The studies found that a significant percentage of patients undergoing endoscopic submucosal dissection had issues like non-curative resections and also highlighted the importance of careful patient selection to improve outcomes.
Can air pollution affect gastrointestinal health?
Yes, Dr. Maresca has found that air pollution can contribute to inflammation and liver conditions, making it an important area of study for patients at risk.

Publications in plain English

Postpartum intramuscular abscess of the biceps femoris in a patient with a history of intravenous drug use.

2026

Radiology case reports

Masino F, Maresca R, Tondo F, Murrone S, Fanigliulo G +6 more

Plain English
This study looked at a rare infection that developed in the thigh of a 28-year-old woman who had recently given birth and had a history of using injectable drugs. After two weeks postpartum, she had a painful swollen thigh, and tests confirmed a large abscess in her muscle. Surgery and antibiotics led to her full recovery, showcasing the importance of recognizing such infections in postpartum women and using MRI for accurate diagnosis. Who this helps: This helps postpartum women, particularly those with a history of drug use.

PubMed

Endoscopic Management of Malignancy-Related Gastrointestinal Bleeding: A Comprehensive Narrative Review.

2026

Medical sciences (Basel, Switzerland)

Salvi D, Parmigiani M, Spada C, Olivari N, Piccirelli S +5 more

Plain English
This study looks at how to manage bleeding in the gastrointestinal tract caused by cancer. It shows that about 10% of cancer patients experience this type of bleeding, which is often hard to control. New imaging techniques and advanced treatment options, like special clips and hemostatic powders, are improving the ability to quickly stop the bleeding and make treatment more effective. Who this helps: This benefits cancer patients and their doctors by providing better treatment options for gastrointestinal bleeding.

PubMed

Endoscopic submucosal dissection and submucosal tunneling endoscopic resection of gastric subepithelial lesions originating from the muscle layer: a multicenter retrospective study.

2026

Annals of gastroenterology

Dimitriadis S, Vogli S, Adrisani G, Tribonias G, Galasso D +26 more

Plain English
This study looked at two advanced methods for removing gastric subepithelial lesions (SELs) that arise from the muscle layer of the stomach. Researchers found that these methods, endoscopic submucosal dissection (ESD) and submucosal tunneling endoscopic resection (STER), were effective in 96.3% of cases, with a low complication rate of 7% and very few recurrences (2.5% after about 9 months). This matters because these techniques can be safer alternatives to traditional surgery, especially for larger lesions or those growing outside the stomach lining. Who this helps: Patients with gastric subepithelial lesions.

PubMed

The Impact of Air Pollution on the Lung-Gut-Liver Axis: Oxidative Stress and Its Role in Liver Disease.

2025

Antioxidants (Basel, Switzerland)

Iaccarino J, Mignini I, Maresca R, Giansanti G, Esposto G +5 more

Plain English
This study examined how air pollution affects a system in the body that connects the lungs, gut, and liver. Researchers found that pollutants can create harmful substances that lead to inflammation and damage, making liver diseases like fatty liver disease and cirrhosis more likely. Understanding these connections is important for developing better ways to prevent or treat liver issues caused by air pollution. Who this helps: This helps patients at risk for liver disease due to air pollution.

PubMed

Clinical outcomes of endoscopic mucosal resection for large superficial nonampullary duodenal epithelial tumor: a single-center study.

2025

European journal of gastroenterology & hepatology

Barbaro F, Papparella LG, Chiappetta MF, Schepis T, Maresca R +6 more

Plain English
This study looked at a treatment called endoscopic mucosal resection (EMR) for large tumors in the duodenum, a part of the small intestine. Researchers reviewed the outcomes of 81 patients who had tumors over 1 cm in size from 2017 to 2021 and found that while 94% had their tumors successfully removed, 20% experienced recurrence within an average follow-up of 20.5 months, particularly among those with larger tumors or prior surgeries. This matters because, even though EMR can effectively treat these tumors, there is a significant chance they may come back, highlighting the need for regular check-ups. Who this helps: Patients with large duodenal tumors and their doctors.

PubMed

Endoscopic hand-suturing for endoscopic submucosal dissection wound closure: a didactic clinical case presentation.

2025

Endoscopy

Barbaro F, Schepis T, Chiappetta MF, Maresca R, Landi R +1 more

PubMed

Effect of Prophylactic Colon ESD (Endoscopic Submucosal Dissection) Defect Closure on Post-ESD Outcomes: An International Multi-center Retrospective Study.

2025

Digestive diseases and sciences

Karna R, Sánchez JC, Josloff K, Tran T, Tiankanon K +27 more

Plain English
This study looked at whether closing the wounds made during a specific colon procedure called endoscopic submucosal dissection (ESD) can help reduce complications, such as bleeding and the need to stay overnight in the hospital. The researchers found that among 560 patients, those who had their wounds closed experienced much lower rates of delayed bleeding (1.7% compared to 5.6%) and less need for overnight hospitalization. Specifically, closing the wounds reduced the risk of delayed bleeding for patients with right-sided polyps by more than half. Who this helps: This benefits patients undergoing colon ESD, especially those with right-sided polyps.

PubMed

Advanced diagnostic and resection endoscopic techniques in managing colitis-associated neoplasia: standard of care or still utopia?

2025

Best practice & research. Clinical gastroenterology

Maresca R, Calabrese G, Marchitto SA, Schepis T, Pecere S +5 more

Plain English
This research looked at how to effectively detect and treat abnormal growths in patients with long-standing inflammatory bowel disease (IBD), which can lead to cancer. They found that choosing the right endoscopic technique is crucial: smaller lesions can be removed with a simpler method, while larger or tougher ones require more advanced techniques to ensure complete removal. Improving these methods is important because it can lead to better health outcomes and potentially reduce the need for major surgeries in patients at risk for cancer due to IBD. Who this helps: This benefits patients with inflammatory bowel disease and their doctors.

PubMed

Rates of Cancer, Non-curative Resection, Adverse Event and Surgery After Colonic Endoscopic Submucosal Dissection (ESD)-Results from a Large International Multicenter Study.

2025

Digestive diseases and sciences

Karna R, Sánchez JC, Josloff K, Tran T, Tiankanon K +27 more

Plain English
This study looked at the outcomes of a procedure called endoscopic submucosal dissection (ESD) used to remove lesions from the colon, specifically focusing on how often cancer was found and how many patients needed further surgery. They found that cancer was present in 12% of the cases, and more than half (59.1%) of the patients had what is called non-curative resection, meaning the procedure didn’t completely remove the cancer. Importantly, only 7.6% of those with non-curative resections needed additional surgery, and there were some complications in 8.8% of patients. This information is important as it shows the need for careful patient and lesion selection to improve outcomes for those undergoing ESD. Who this helps: This helps doctors and patients considering ESD for colon lesions.

PubMed

Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial.

2025

Nutrients

Laterza L, Cremon C, Coppola G, Settanni CR, Maresca R +14 more

Plain English
This study looked at whether a combination of multistrain probiotics and vitamin D could improve gut health in people with irritable bowel syndrome (IBS) who don't have constipation. Researchers found that after 12 weeks, participants who took the probiotics and vitamin D had a notable decrease in a marker indicating gut permeability (zonulin) and better stool consistency compared to those who took a placebo. Specifically, they experienced a 19.5 ng/mL reduction in zonulin levels and improvements in stool quality and frequency. Who this helps: This helps patients with irritable bowel syndrome, particularly those without constipation.

PubMed

The Brain Tumor Segmentation - Metastases (BraTS-METS) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI.

2024

ArXiv

Moawad AW, Janas A, Baid U, Ramakrishnan D, Saluja R +227 more

Plain English
The BraTS-METS 2023 challenge focused on improving how we identify and segment brain metastases (cancer spread to the brain) in MRI scans before treatment. The best performing algorithm scored a mean of 7.9 on how accurately it identified lesions, with a Dice score of 0.65. This is important because it highlights ongoing challenges in detecting smaller tumors and aims to enhance the accuracy of brain tumor evaluations, ultimately improving care for patients with brain metastases. Who this helps: This benefits patients with brain metastases and their healthcare providers.

PubMed

Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together.

2024

International journal of molecular sciences

Maresca R, Mignini I, Varca S, Calvez V, Termite F +6 more

Plain English
This research paper looks at how inflammatory bowel diseases (IBD), like Crohn's disease and ulcerative colitis, are connected to non-alcoholic fatty liver disease (NAFLD), which is the most common liver issue globally. It finds that patients with IBD are more likely to develop NAFLD and its serious forms, such as liver scarring, with up to 50% experiencing liver-related complications. Understanding this link is crucial because it can help improve treatment and quality of life for IBD patients who also have liver problems. Who this helps: This research benefits patients with inflammatory bowel diseases and their doctors.

PubMed

Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.

2024

Expert opinion on biological therapy

Tursi A, Mocci G, Scaldaferri F, Napolitano D, Maresca R +58 more

Plain English
This study looked at the drug ustekinumab (UST) to see how well it works and how safe it is for patients with ulcerative colitis (UC). Researchers followed 256 patients and found that by 24 weeks, 27.6% of them achieved clinical remission, and 61.8% showed a clinical response. The study also noted that only a small number of patients experienced adverse effects (2.3%), which indicates that UST can be a safe and effective option for treating UC. Who this helps: Patients suffering from ulcerative colitis.

PubMed

Clinical, Radiological, and Surgical Risk Factors for Endoscopic Anastomotic Recurrence Following Surgery in Crohn's Disease.

2024

Journal of clinical medicine

Minordi LM, Sacchetti F, Balzano D, Maresca R, D'Angelo FB +9 more

Plain English
This study looked at factors that contribute to the likelihood of Crohn's disease returning after surgery to remove part of the intestines. Out of 63 patients, 24 (38%) experienced a return of the disease within two years. Key findings showed that the older a patient was when they had the surgery, and specific characteristics of their disease, such as the location and extent of the affected bowel, increased the chances of recurrence. Who this helps: This research benefits patients with Crohn's disease and their doctors by identifying risks that can inform treatment decisions.

PubMed

Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis.

2024

Journal of personalized medicine

Laterza L, Piscaglia AC, Bibbò S, Arena V, Brisigotti M +12 more

Plain English
This study looked at patients with ulcerative colitis who appeared to have healed mucosal tissue but still had signs of ongoing disease activity in their tissue samples. Out of 100 patients, only 2 showed no remaining signs of disease. The research found that certain conditions in the tissue, like basal plasmacytosis and surface irregularity, were linked to a higher chance of the disease coming back; specifically, patients with these features were 2.98 to 4.50 times more likely to relapse. Who this helps: This helps patients with ulcerative colitis and their doctors by identifying risks for disease reactivation.

PubMed

Coronary calcifications as a new prognostic marker in COVID-19 patients: role of CT.

2023

European review for medical and pharmacological sciences

Maggialetti N, Torrente A, Lazzari P, Villanova I, Marvulli P +7 more

Plain English
This study looked at how coronary artery calcification, which can be measured using CT scans, relates to death rates in patients with COVID-19. Researchers found that higher levels of calcification were linked to higher mortality rates: 10.1% of patients with no calcification died, while 46.4% of those with significant calcification (scores between 9 and 12) passed away. This is important because it shows that measuring heart artery calcification can help predict which COVID-19 patients are at greater risk of dying. Who this helps: Patients with COVID-19 and their healthcare providers.

PubMed

Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies.

2023

Thrombosis research

Papa A, Santini P, De Lucia SS, Maresca R, Porfidia A +4 more

Plain English
This study looked at how the gut bacteria in patients with inflammatory bowel disease (IBD) can lead to an increased risk of dangerous blood clots. Researchers found that certain bacteria-related substances, like LPS and TMAO, may trigger these blood clot risks by causing ongoing inflammation, even when the disease isn't active. Understanding this connection is important because it can help develop new treatments aimed at restoring healthy gut bacteria and reducing the chances of blood clots. Who this helps: This research benefits patients with inflammatory bowel disease and their doctors.

PubMed

Nutrition in Acute Pancreatitis: From the Old Paradigm to the New Evidence.

2023

Nutrients

De Lucia SS, Candelli M, Polito G, Maresca R, Mezza T +7 more

Plain English
This research paper looks at how nutrition is managed in patients with acute pancreatitis, highlighting a shift from an older method that involved resting the pancreas, to a newer approach that encourages early oral or tube feeding. The findings show that early feeding can lead to better outcomes, including a 30% lower risk of multiple-organ failure and reduced mortality rates. This is important because it suggests that changing how we feed patients could directly improve their chances of recovery. Who this helps: This helps patients recovering from acute pancreatitis.

PubMed

Predicting Treatment Response in Inflammatory Bowel Diseases: Cross-Sectional Imaging Markers.

2023

Journal of clinical medicine

Mignini I, Maresca R, Ainora ME, Larosa L, Scaldaferri F +2 more

Plain English
This study looked at how doctors can better predict which treatments will work for patients with inflammatory bowel diseases (IBD), like Crohn's disease and ulcerative colitis, by using imaging techniques like ultrasounds and MRIs. Researchers found that specific imaging markers can help identify whether a patient will respond well to new biological drugs. This new approach can lead to more personalized treatment plans, improving patient care. Who this helps: This helps patients with inflammatory bowel diseases.

PubMed

State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine.

2023

Cancers

Schepis T, De Lucia SS, Pellegrino A, Del Gaudio A, Maresca R +6 more

Plain English
This study looked at the current state and future developments in treating pancreatic cancer, a type of cancer that is difficult to diagnose early and has high death rates. Researchers found that while surgery is the only way to potentially cure pancreatic cancer, most patients are diagnosed too late for this option. Improvements in surgical techniques and other therapies have made treatment safer and more effective, but a personalized approach is crucial for each patient to determine the best treatment plan. Who this helps: This helps patients with pancreatic cancer and their doctors by providing better treatment options and strategies.

PubMed

Radiomics could predict surgery at 10 years in Crohn's disease.

2023

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Laterza L, Boldrini L, Tran HE, Votta C, Larosa L +10 more

Plain English
This study looked at how analyzing medical images can help predict whether patients with Crohn's disease will need surgery within the next 10 years. Researchers examined CT scans from 30 patients and developed a model that successfully identified patients at high risk for surgery with an accuracy of about 83%. This ability to predict surgery can help doctors monitor patients more closely and tailor treatments to those who need it most. Who this helps: Patients with Crohn's disease and their doctors.

PubMed

Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment.

2023

Journal of clinical medicine

Maresca R, Varca S, Di Vincenzo F, Ainora ME, Mignini I +6 more

Plain English
This research paper examines the role of cytomegalovirus (CMV) infection in patients with inflammatory bowel disease (IBD), especially those with ulcerative colitis. It highlights that IBD patients may be particularly vulnerable to CMV due to weakened immune systems, and discusses the ongoing debate about the best ways to diagnose CMV infections and their impact on treatment resistance, particularly concerning steroid medications. Addressing CMV infections may improve management of IBD, leading to better outcomes for patients. Who this helps: Patients with inflammatory bowel disease, especially those struggling with treatment.

PubMed

Is food refusal in autistic children related to TAS2R38 genotype?

2018

Autism research : official journal of the International Society for Autism Research

Riccio MP, Franco C, Negri R, Ferrentino RI, Maresca R +3 more

Plain English
This study looked at whether genetic differences in how children taste bitterness affect their food preferences, particularly in children with autism spectrum disorder (ASD). Researchers tested 43 children with ASD and 41 typically developing children, finding that those with ASD who are sensitive to bitter tastes tend to refuse more foods. Specifically, they discovered a stronger presence of a specific gene variant related to bitter sensitivity in ASD children who are selective about food, which could help caregivers create better meal plans for these children. Who this helps: This helps children with autism and their families by providing insights into managing food preferences.

PubMed

Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.

2017

Mycopathologia

Iovene MR, Bombace F, Maresca R, Sapone A, Iardino P +7 more

Plain English
This study examined the gut health of individuals with Autism Spectrum Disorders (ASD) and found that 57.5% of these subjects had high levels of a type of yeast called Candida, which was not present in healthy individuals. The researchers also discovered that individuals with ASD had lower levels of beneficial bacteria and signs of mild gut inflammation, which were linked to more severe symptoms of autism. Understanding these gut issues could lead to new treatments that improve health and quality of life for people with ASD. Who this helps: This helps patients with autism and their families.

PubMed

Lessons Learned: Accessing the Voice of Nurses to Improve a Novice Nurse Program.

2015

Journal for nurses in professional development

Maresca R, Eggenberger T, Moffa C, Newman D

Plain English
This study looked at a training program for new nurses at a community hospital to see how well it supports them as they start their careers. The researchers found that gathering feedback from these novice nurses helped identify important lessons for improving the program. Specifically, listening to their experiences can lead to better support for new nurses, making their transition smoother and more effective. Who this helps: This helps new nurses by improving their training and support as they begin their nursing careers.

PubMed

Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder.

2014

In vivo (Athens, Greece)

Gentile I, Zappulo E, Bonavolta R, Maresca R, Messana T +7 more

Plain English
This study looked at whether children with autism spectrum disorder (ASD) have different levels of antibodies to two viruses, Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV), compared to healthy children. The researchers found that both groups had similar levels of these antibodies, but children with ASD who had CMV antibodies tended to have more severe symptoms. This is important because it helps clarify that while CMV and EBV might not directly cause ASD, they could be linked to the severity of the condition in some children. Who this helps: This helps doctors and researchers working with children with autism.

PubMed

Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study.

2014

In vivo (Athens, Greece)

Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP +6 more

Plain English
This study looked at how many children with autism spectrum disorder (ASD) have been exposed to the Varicella Zoster Virus (the virus that causes chickenpox) compared to healthy children. They found that 59% of the children with ASD had antibodies to this virus, compared to only 39% of the healthy controls, and the levels of these antibodies were much higher in the ASD group (694 mIU/ml vs. 94 mIU/ml). This finding is important because it suggests a possible link between exposure to this virus and the development of ASD, which could lead to new ways to understand and support children with this condition. Who this helps: This helps researchers and healthcare providers working with children with autism.

PubMed

Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders.

2014

In vivo (Athens, Greece)

Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP +7 more

Plain English
This study looked at the presence of antibodies to herpes simplex virus types 1 and 2 in children with autism spectrum disorders (ASD) compared to healthy children. Researchers tested 54 children with ASD and 46 healthy children and found no significant differences in antibody levels or rates of exposure to these viruses. This means that herpes simplex viruses do not appear to be linked to the development of autism spectrum disorders. Who this helps: This research is useful for doctors and researchers studying the causes of autism.

PubMed

Effect of caffeine ingestion on muscular strength and endurance: a meta-analysis.

2010

Medicine and science in sports and exercise

Warren GL, Park ND, Maresca RD, McKibans KI, Millard-Stafford ML

Plain English
This study looked at how caffeine affects muscle strength and endurance based on 34 different research papers. It found that caffeine can boost muscle strength by about 7% in the knee extensors and enhance endurance in certain types of tests by roughly 18%. This is important because it shows that caffeine can help people perform better during physical activities. Who this helps: This helps athletes and anyone looking to improve their physical performance.

PubMed

Caffeines enhancement of maximal voluntary strength and activation in uninjured but not injured muscle.

2008

International journal of sport nutrition and exercise metabolism

Park ND, Maresca RD, McKibans KI, Morgan DR, Allen TS +1 more

Plain English
This study looked at whether taking caffeine could help improve muscle strength and activation after injury. Researchers found that caffeine increased voluntary strength by 10.4% and muscle activation by 6.2% in healthy (uninjured) muscle but had no effect on injured muscle. These findings are important because they suggest that caffeine can help enhance strength in healthy muscles, which could be useful for athletes and active individuals. Who this helps: This helps athletes and fitness enthusiasts looking to boost their muscle performance.

PubMed

Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.

2004

Vaccine

Mattion N, König G, Seki C, Smitsaart E, Maradei E +14 more

Plain English
This research focused on the foot-and-mouth disease outbreaks in Argentina between 2000 and 2002, identifying different strains of the virus and improving vaccines to control the disease. The study found two main serotypes (O and A) and revealed that updating vaccines was crucial; after new vaccines were used, outbreaks decreased significantly, and over 75% of cattle developed protective antibodies. This is important because it shows how effective vaccination can control a serious livestock disease, ensuring food security and animal health. Who this helps: This helps farmers, veterinarians, and the livestock industry.

PubMed

Finding strength to face breast cancer. Interview by Sandy Rensvold.

2000

Journal of Christian nursing : a quarterly publication of Nurses Christian Fellowship

Maresca R

PubMed

Clinical study of gastrointestinal complications associated with clindamycin therapy.

1977

The Journal of infectious diseases

Swartzberg JE, Maresca RM, Remington JS

Plain English
This study looked at gastrointestinal problems, specifically diarrhea, in 1,000 patients being treated with clindamycin. Researchers found that 6.6% of the patients experienced diarrhea, with higher rates among women and those over 20 years old, but the amount of the drug taken or how long it was used didn't affect the likelihood of getting diarrhea. Most of the patients who experienced diarrhea started having symptoms within two days of starting the medication, and on average, it lasted about 11 days. Who this helps: This information helps doctors better understand the risks of clindamycin therapy and identify patients who may be more vulnerable to diarrhea.

PubMed

Gastrointestinal side effects associated with clinidamycin. 1,000 consecutive patients.

1976

Archives of internal medicine

Swartzberg JE, Maresca RM, Remington JS

Plain English
This study looked at how often diarrhea happens in patients taking clindamycin, an antibiotic, by examining 1,000 people. They found that 66 patients (6.6%) experienced diarrhea, and for three of those patients, it was severe. The study showed that older adults (over 20 years) and women were more likely to experience this side effect, while the amount of medication taken or how it was given did not affect the chances of having diarrhea. Who this helps: This information helps doctors understand the risk of diarrhea with clindamycin, particularly in older women.

PubMed

Silicic acid chromatography of organic acids in blood cells and biological fluids.

1970

Clinical chemistry

Barness LA, Morrow G, Nocho RE, Maresca RA

PubMed

The size of tracheotomy tubes; its effect on ventilation of respirator patients with poliomyelitis.

1956

The Annals of otology, rhinology, and laryngology

MARESCA RL, OKINO SY

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.